Citius Pharmaceuticals Inc

NASDAQ:CTXR   3:59:28 PM EDT
0.89
-0.01 (-1.23%)
Earnings Announcements

Citius Pharmaceuticals Reports Fiscal Q2 2022 Results

Published: 05/12/2022 20:43 GMT
Citius Pharmaceuticals Inc (CTXR) - Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2022 Financial Results and Provides Business Update.
Q2 Loss per Share $0.05.
Q2 Earnings per Share View $-0.07 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.